We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Sues FDA For Delaying Duragesic Generic

Law360 (June 23, 2004, 12:00 AM EDT) -- Mylan Laboratories Inc. has sued the U.S. Food and Drug Administration for delaying introduction of the company's generic version of Johnson & Johnson’s Duragesic pain-relief skin patch.

The largest U.S. generic drug maker also suspended its earnings forecast on Wednesday as its shares fell on the news that the company would not be able to sell the skin patch as early as previously indicated.

On Tuesday, the FDA granted Johnson & Johnson, which makes Duragesic, an additional six months of marketing exclusivity for the treatment. That...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.